Intratio
Loading...
Skip to main content
Stock comparison · Signal date 2026-11-04

ALMS vs ANNX: stock comparison and AI forecast

Alumis Inc. (ALMS) and Annexon, Inc. (ANNX) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market

Share
Nasdaq · Pharmaceutical Preparations

ALMS Alumis Inc.

Price
$6.50 -75.1% · 6M
Market Cap
$841M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Nasdaq · Pharmaceutical Preparations

ANNX Annexon, Inc.

Price
$4.19 -26.7% · 6M
Market Cap
$794M
P/E Ratio
–
Size
small-cap
AI Forecast
Full analysis →
Model output

Which one does the AI model favor?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

6M · 2026-05-05 → 2026-11-04

Six-month price performance

Closing prices rebased to 100 at the start of the window.

255075100
ALMS -75.1% ANNX -26.7%
ALMS · ANNX

Key facts

  • ALMS and ANNX have similar market capitalizations ($841M and $794M).
  • Over the last six months ANNX returned -26.7% and ALMS -75.1%.
  • ANNX carries 0.31 times debt per unit of equity, against 0.24 times for ALMS.
  • Both companies share the SEC industry classification Pharmaceutical Preparations.
Fundamentals

Fundamentals side by side

Trailing twelve months.

Valuation & Market

MetricALMSANNX
Market Cap$841M$794M
P/B Ratio1.86x3.75x
EPS$-2.92$-1.28
Book Value/Share$3.49$1.12
Revenue/Share$0.06–
FCF/Share$-2.72$-1.02

Profitability & Margins

MetricALMSANNX
ROE-97.1%-91.4%
ROA-78.3%–
ROIC-94.8%–
Operating Margin-6204.4%–
Net Margin-5933.4%–
EBT Margin-5994.9%–
Tax Rate2.3%–

Financial Health

MetricALMSANNX
Current Ratio6.74x5.53x
D/E Ratio0.24x0.31x
Financial Leverage1.24x–
Working Capital$438M$174M

Cash Flow

MetricALMSANNX
Operating Cash Flow-$351M-$193M
Free Cash Flow-$352M-$193M
Capital Spending-$400K-$180K
FCF/Sales-4755.3%–
CapEx/Sales5.4%–

Operational Efficiency

MetricALMSANNX
Asset Turnover0.01x–
Fixed Assets Turnover0.4x–

Income Statement

MetricALMSANNX
Total Revenue$7M–
Operating Income-$459M-$211M
Net Income-$439M-$193M
R&D Expense$348M$175M

Dividend & Shareholder Information

MetricALMSANNX
Shares Outstanding129M190M
FAQ

ALMS vs ANNX: stock comparison and AI forecast

Which is bigger, ALMS or ANNX?

ALMS and ANNX have similar market capitalizations ($841M and $794M).

Which stock performed better over the last six months, ALMS or ANNX?

Over the last six months ANNX returned -26.7% and ALMS -75.1%.

Which one does Intratio's AI model rank higher, ALMS or ANNX?

Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.

Compare

More comparisons

This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.